1. Home
  2. BLBD vs MNKD Comparison

BLBD vs MNKD Comparison

Compare BLBD & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Bird Corporation

BLBD

Blue Bird Corporation

N/A

Current Price

$49.73

Market Cap

1.7B

ML Signal

N/A

Logo MannKind Corporation

MNKD

MannKind Corporation

N/A

Current Price

$5.90

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BLBD
MNKD
Founded
1927
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
BLBD
MNKD
Price
$49.73
$5.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$64.60
$10.08
AVG Volume (30 Days)
460.2K
3.5M
Earning Date
02-04-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
22.79
23.47
EPS
3.88
0.10
Revenue
$1,480,099,000.00
$313,787,000.00
Revenue This Year
$4.86
$21.40
Revenue Next Year
$3.41
$25.03
P/E Ratio
$12.64
$58.33
Revenue Growth
9.87
17.43
52 Week Low
$30.04
$3.38
52 Week High
$61.95
$6.51

Technical Indicators

Market Signals
Indicator
BLBD
MNKD
Relative Strength Index (RSI) 51.68 57.49
Support Level $47.43 $5.03
Resistance Level $50.34 $5.68
Average True Range (ATR) 1.41 0.26
MACD 0.25 -0.01
Stochastic Oscillator 81.82 60.47

Price Performance

Historical Comparison
BLBD
MNKD

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: